Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
133 hedge funds and large institutions have $670M invested in Flexion Therapeutics, Inc. in 2019 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 28 increasing their positions, 42 reducing their positions, and 21 closing their positions.
305% more call options, than puts
Call options by funds: $19M | Put options by funds: $4.7M
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
43% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 21
42% more capital invested
Capital invested by funds: $472M → $670M (+$198M)
6% more funds holding
Funds holding: 126 → 133 (+7)
33% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 42
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$14.1M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$5.24M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
+$3.59M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$3.29M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$16.6M |
| 2 |
CC
Clearline Capital
New York
|
-$10.9M |
| 3 |
Bank of New York Mellon
New York
|
-$9.98M |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$9.82M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$9M |
FLXN Hedge Fund Activity: Q4 2019 in Review
133 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q4 2019, worth a combined $670M — up 42% from $472M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new FLXN positions and 21 closed out — a net gain of 9 holders — while 28 added to existing stakes and 42 trimmed.
The largest buyer was Artisan Partners, opening a new position worth an estimated $14.1M. The largest seller was Morgan Stanley, cutting an estimated $16.6M.
- 133 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q4 2019, up from 126 in Q3 2019.
- Funds reported $670M of Flexion Therapeutics, Inc. stock for Q4 2019, up 42% quarter-over-quarter.
- 30 funds opened new Flexion Therapeutics, Inc. positions in Q4 2019 and 21 closed out, a net change of +9 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q4 2019 was Artisan Partners, an estimated $14.1M added.
- The largest Flexion Therapeutics, Inc. seller in Q4 2019 was Morgan Stanley, an estimated $16.6M sold.
Based on aggregated 13F filings for Q4 2019.